Humatica advises the Riverside Company on their recent investment in Alter Pharma

Humatica Ltd. was retained to advise the Riverside Company on its investment in Alter Pharma, a Belgian pharmaceutical group. Alter Pharma distributes EU-sourced pharmaceutical products to wholesalers pharmacies and hospitals. It also develops and reformulates generic pharmaceuticals using GMP approved third-party manufacturers, and sells them internationally through partnerships

Humatica provided organisational due diligence services for this transaction.

To view press release: Humatica Advisor to Riverside for AlterPharma